(CPB) Campbell’s - Ratings and Ratios
Soups, Sauces, Juices, Snacks, Beverages, Pasta
CPB EPS (Earnings per Share)
CPB Revenue
Description: CPB Campbell’s
The Campbells Company is a leading manufacturer and marketer of food and beverage products, operating through two main segments: Meals & Beverages and Snacks. The Meals & Beverages segment offers a diverse portfolio of brands, including Campbells, Swanson, Prego, Pace, and Raos, across various categories such as soups, sauces, and juices. The Snacks segment features brands like Pepperidge Farm, Snyders of Hanover, Lance, and Kettle Brand, offering a range of snacking products.
From a business perspective, Campbells has a strong presence in the US and Canada, with a growing footprint in Latin America. The companys products are sold through various channels, including retail food chains, mass discounters, e-commerce, and convenience stores. With a history dating back to 1869, Campbells has established itself as a trusted brand, leveraging its scale and distribution network to drive growth.
To further analyze Campbells performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin can be examined. For instance, Campbells has been focusing on portfolio optimization, divesting non-core brands and investing in marketing and innovation to drive growth. Additionally, metrics like return on equity (RoE) of 11.78% and a forward P/E ratio of 10.74 suggest a relatively stable and profitable business. Other relevant KPIs could include sales growth, market share, and dividend yield, which can provide insights into the companys ability to generate returns for shareholders.
From a valuation perspective, Campbells common stock (CPB) can be evaluated using metrics like price-to-sales (P/S) ratio, enterprise value-to-EBITDA (EV/EBITDA) ratio, and dividend yield. These metrics can help determine whether the stock is fairly valued, undervalued, or overvalued relative to its peers and the broader market. By analyzing these KPIs, investors can gain a more comprehensive understanding of Campbells financial health, competitive position, and growth prospects.
CPB Stock Overview
| Market Cap in USD | 10,056m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | 1985-07-01 |
CPB Stock Ratings
| Growth Rating | -53.9% |
| Fundamental | 53.0% |
| Dividend Rating | 57.0% |
| Return 12m vs S&P 500 | -44.2% |
| Analyst Rating | 3.13 of 5 |
CPB Dividends
| Dividend Yield 12m | 4.37% |
| Yield on Cost 5y | 3.99% |
| Annual Growth 5y | 1.12% |
| Payout Consistency | 94.6% |
| Payout Ratio | 51.7% |
CPB Growth Ratios
| Growth Correlation 3m | 73.9% |
| Growth Correlation 12m | -94.4% |
| Growth Correlation 5y | -8.1% |
| CAGR 5y | -8.90% |
| CAGR/Max DD 3y | -0.21 |
| CAGR/Mean DD 3y | -0.45 |
| Sharpe Ratio 12m | -1.40 |
| Alpha | -40.32 |
| Beta | 0.345 |
| Volatility | 22.02% |
| Current Volume | 4133.3k |
| Average Volume 20d | 5710.8k |
| Stop Loss | 31.8 (-3.3%) |
| Signal | -0.35 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (602.0m TTM) > 0 and > 6% of Revenue (6% = 615.2m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -27.06% (prev -14.38%; Δ -12.67pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.14b > Net Income 602.0m (YES >=105%, WARN >=100%) |
| Net Debt (6.72b) to EBITDA (1.56b) ratio: 4.32 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.05 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (299.0m) change vs 12m ago 0.34% (target <= -2.0% for YES) |
| Gross Margin 30.42% (prev 30.83%; Δ -0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 68.06% (prev 63.25%; Δ 4.81pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.26 (EBITDA TTM 1.56b / Interest Expense TTM 345.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.30
| (A) -0.19 = (Total Current Assets 132.0m - Total Current Liabilities 2.91b) / Total Assets 14.90b |
| (B) 0.31 = Retained Earnings (Balance) 4.67b / Total Assets 14.90b |
| (C) 0.07 = EBIT TTM 1.12b / Avg Total Assets 15.07b |
| (D) 0.0 = Book Value of Equity 0.0 / Total Liabilities 10.99b |
| Total Rating: 0.30 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.98
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 3.76% = 1.88 |
| 3. FCF Margin 6.88% = 1.72 |
| 4. Debt/Equity 2.27 = 0.37 |
| 5. Debt/Ebitda 5.68 = -2.50 |
| 6. ROIC - WACC 3.26% = 4.07 |
| 7. RoE 15.51% = 1.29 |
| 8. Rev. Trend 19.76% = 0.99 |
| 9. Rev. CAGR -3.71% = -0.62 |
| 10. EPS Trend -26.07% = -0.65 |
| 11. EPS CAGR -16.56% = -2.07 |
What is the price of CPB shares?
Over the past week, the price has changed by -3.04%, over one month by +1.11%, over three months by +3.15% and over the past year by -33.69%.
Is Campbell’s a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CPB is around 29.98 USD . This means that CPB is currently overvalued and has a potential downside of -8.79%.
Is CPB a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 12
- Sell: 3
- Strong Sell: 2
What are the forecasts/targets for the CPB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.6 | 5.2% |
| Analysts Target Price | 34.6 | 5.2% |
| ValueRay Target Price | 32.2 | -2.2% |
Last update: 2025-09-06 02:46
CPB Fundamental Data Overview
CCE Cash And Equivalents = 132.0m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.7487
P/E Forward = 12.1803
P/S = 0.9808
P/B = 2.5984
P/EG = 0.6443
Beta = 0.053
Revenue TTM = 10.25b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.56b USD
Long Term Debt = 8.09b USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 762.0m USD (from shortTermDebt, last quarter)
Debt = 8.85b USD (Calculated: Short Term 762.0m + Long Term 8.09b)
Net Debt = 6.72b USD (from netDebt column, last quarter)
Enterprise Value = 18.77b USD (10.06b + Debt 8.85b - CCE 132.0m)
Interest Coverage Ratio = 3.26 (Ebit TTM 1.12b / Interest Expense TTM 345.0m)
FCF Yield = 3.76% (FCF TTM 705.0m / Enterprise Value 18.77b)
FCF Margin = 6.88% (FCF TTM 705.0m / Revenue TTM 10.25b)
Net Margin = 5.87% (Net Income TTM 602.0m / Revenue TTM 10.25b)
Gross Margin = 30.42% ((Revenue TTM 10.25b - Cost of Revenue TTM 7.13b) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 18.77b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.96% (Interest Expense 85.0m / Debt 8.85b)
Taxrate = 24.37% (194.0m / 796.0m)
NOPAT = 850.1m (EBIT 1.12b * (1 - 24.37%))
Current Ratio = 0.05 (Total Current Assets 132.0m / Total Current Liabilities 2.91b)
Debt / Equity = 2.27 (Debt 8.85b / last Quarter total Stockholder Equity 3.90b)
Debt / EBITDA = 5.68 (Net Debt 6.72b / EBITDA 1.56b)
Debt / FCF = 12.55 (Debt 8.85b / FCF TTM 705.0m)
Total Stockholder Equity = 3.88b (last 4 quarters mean)
RoA = 4.04% (Net Income 602.0m, Total Assets 14.90b )
RoE = 15.51% (Net Income TTM 602.0m / Total Stockholder Equity 3.88b)
RoCE = 9.39% (Ebit 1.12b / (Equity 3.88b + L.T.Debt 8.09b))
RoIC = 7.48% (NOPAT 850.1m / Invested Capital 11.37b)
WACC = 4.22% (E(10.06b)/V(18.90b) * Re(7.29%)) + (D(8.85b)/V(18.90b) * Rd(0.96%) * (1-Tc(0.24)))
Shares Correlation 3-Years: -42.20 | Cagr: -0.06%
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 77.66% ; FCFE base≈690.2m ; Y1≈662.0m ; Y5≈646.1m
Fair Price DCF = 38.65 (DCF Value 11.52b / Shares Outstanding 298.1m; 5y FCF grow -5.44% → 3.0% )
Revenue Correlation: 19.76 | Revenue CAGR: -3.71%
Rev Growth-of-Growth: 2.84
EPS Correlation: -26.07 | EPS CAGR: -16.56%
EPS Growth-of-Growth: -1.09
Additional Sources for CPB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle